Squarepoint Ops LLC Amneal Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$80.7 Billion
Q1 2025

A detailed history of Squarepoint Ops LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 152,150 shares of AMRX stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,150

Previous 124,744 21.97%

Holding current value

$1.09 Million

Previous $987,000 29.18%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$7.72 - $9.01 $211,574 - $246,928	27,406 Added 21.97%	152,150 $1.28 Million
Q4 2024 Feb 14, 2025	BUY	$7.69 - $9.25 $809,510 - $973,729	105,268 Added 540.5%	124,744 $987,000
Q3 2024 Nov 14, 2024	SELL	$6.42 - $8.83 $589,343 - $810,576	-91,798 Reduced 82.5%	19,476 $162,000
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $596,428 - $791,158	111,274 New	111,274 $706,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $77,788 - $165,377	61,251 Added 265.65%	84,308 $117,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $45,191 - $60,178	23,057 New	23,057 $45,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $106,268 - $157,460	-35,305 Reduced 38.96%	55,303 $176,000
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $149,451 - $187,389	38,321 Added 73.29%	90,608 $378,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $12,004 - $17,778	-3,039 Reduced 5.49%	52,287 $250,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $83,066 - $108,699	-19,273 Reduced 25.84%	55,326 $295,000
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $381,946 - $508,765	74,599 New	74,599 $382,000
Q1 2021 May 17, 2021	SELL	$4.74 - $7.38 $440,981 - $686,590	-93,034 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.95 - $5.42 $279,355 - $383,318	-70,723 Reduced 43.19%	93,034 $425,000
Q3 2020 Nov 16, 2020	BUY	$3.54 - $5.27 $538,175 - $801,182	152,027 Added 1296.05%	163,757 $635,000
Q2 2020 Aug 14, 2020	SELL	$2.87 - $5.46 $76,649 - $145,820	-26,707 Reduced 69.48%	11,730 $56,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $896,598 - $1.95 Million	-364,471 Reduced 90.46%	38,437 $134,000
Q4 2019 Feb 14, 2020	SELL	$2.65 - $5.56 $18,801 - $39,448	-7,095 Reduced 1.73%	402,908 $1.94 Million
Q3 2019 Nov 14, 2019	BUY	$2.29 - $7.1 $938,906 - $2.91 Million	410,003 New	410,003 $1.19 Million
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $1.85 Million - $4.1 Million	-286,808 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $2.57 Million - $3.21 Million	216,251 Added 306.49%	286,808 $4.06 Million
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $923,591 - $1.52 Million	70,557 New	70,557 $955,000

Others Institutions Holding AMRX

# of Institutions

244

Shares Held

136M

Call Options Held

302K

Put Options Held

103K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.09B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Amneal Pharmaceuticals, Inc. Transaction History